Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency
Recruiting
N/A
Interventional Study
Primary Immunodeficiency
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 6 – 18
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 40 (estimated)
- Sponsor
- Gazi University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Primary immunodeficiencies (PID) are a heterogeneous group of diseases that occur as a result of disorders that affect the development, differentiation and/or function of various cells and building blocks in the immune system. Among the symptoms and complications of PID, pulmonary complications are very common and significantly increase the morbidity and mortality of the disease.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
-Patients aged 6-18 years with primary immunodeficiency
Exclusion Criteria:
* Acute pulmonary exacerbation, acute upper or lower respiratory tract infection
* Serious neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical funct…
Contacts